Dr. Reddy's Laboratories Files Form 6-K

Ticker: RDY · Form: 6-K · Filed: Dec 2, 2024 · CIK: 1135951

Sentiment: neutral

Topics: reporting, foreign-private-issuer

TL;DR

DRL filed a 6-K on Dec 2, 2024. Standard foreign issuer report.

AI Summary

Dr. Reddy's Laboratories Limited filed a Form 6-K on December 2, 2024, reporting information as of December 1, 2024. The filing is a report of a foreign private issuer pursuant to SEC rules. The company is based in Hyderabad, India, and its fiscal year ends on March 31.

Why It Matters

This filing provides routine updates for foreign private issuers, ensuring transparency for investors regarding the company's reporting status.

Risk Assessment

Risk Level: low — This filing is a routine report for a foreign private issuer and does not contain significant new financial or operational information.

Key Players & Entities

FAQ

What type of filing is this?

This is a Form 6-K, a Report of Foreign Private Issuer.

Who is the filer?

The filer is Dr. Reddy's Laboratories Limited.

When was this filing submitted?

The filing was submitted on December 2, 2024.

What is the principal executive office location?

The principal executive office is located at 8-2-337, Road No. 3, Banjara Hills, Hyderabad, Telangana 500 034, India.

Does the company file annual reports under Form 20-F or 40-F?

The company indicates it files annual reports under Form 20-F.

Filing Stats: 402 words · 2 min read · ~1 pages · Grade level 16.8 · Accepted 2024-12-02 06:28:26

Filing Documents

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. DR. REDDY’S LABORATORIES LIMITED (Registrant) Date: December 01, 2024 By: /s/ K Randhir Singh Name: K Randhir Singh Title: Company Secretary 3

View Full Filing

View this 6-K filing on SEC EDGAR

View on Read The Filing